rs17882023

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_024006.6(VKORC1):​c.284-673A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0786 in 151,654 control chromosomes in the GnomAD database, including 746 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.079 ( 746 hom., cov: 31)

Consequence

VKORC1
NM_024006.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.707

Publications

3 publications found
Variant links:
Genes affected
VKORC1 (HGNC:23663): (vitamin K epoxide reductase complex subunit 1) This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
VKORC1 Gene-Disease associations (from GenCC):
  • vitamin K-dependent clotting factors, combined deficiency of, type 2
    Inheritance: Unknown, AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • vitamin K-dependent clotting factors, combined deficiency of, type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.17 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024006.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VKORC1
NM_024006.6
MANE Select
c.284-673A>G
intron
N/ANP_076869.1
VKORC1
NM_001311311.2
c.368-673A>G
intron
N/ANP_001298240.1
VKORC1
NM_206824.3
c.174-673A>G
intron
N/ANP_996560.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VKORC1
ENST00000394975.3
TSL:1 MANE Select
c.284-673A>G
intron
N/AENSP00000378426.2
ENSG00000255439
ENST00000529564.1
TSL:4
c.283+1297A>G
intron
N/AENSP00000431371.1
VKORC1
ENST00000319788.11
TSL:1
c.366-673A>G
intron
N/AENSP00000326135.7

Frequencies

GnomAD3 genomes
AF:
0.0786
AC:
11917
AN:
151540
Hom.:
742
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0173
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.175
Gnomad ASJ
AF:
0.0503
Gnomad EAS
AF:
0.00155
Gnomad SAS
AF:
0.0679
Gnomad FIN
AF:
0.135
Gnomad MID
AF:
0.0159
Gnomad NFE
AF:
0.0949
Gnomad OTH
AF:
0.0792
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0786
AC:
11927
AN:
151654
Hom.:
746
Cov.:
31
AF XY:
0.0819
AC XY:
6069
AN XY:
74090
show subpopulations
African (AFR)
AF:
0.0173
AC:
716
AN:
41398
American (AMR)
AF:
0.176
AC:
2668
AN:
15192
Ashkenazi Jewish (ASJ)
AF:
0.0503
AC:
174
AN:
3462
East Asian (EAS)
AF:
0.00155
AC:
8
AN:
5148
South Asian (SAS)
AF:
0.0678
AC:
326
AN:
4810
European-Finnish (FIN)
AF:
0.135
AC:
1410
AN:
10466
Middle Eastern (MID)
AF:
0.0172
AC:
5
AN:
290
European-Non Finnish (NFE)
AF:
0.0950
AC:
6445
AN:
67872
Other (OTH)
AF:
0.0779
AC:
164
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
521
1042
1564
2085
2606
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0976
Hom.:
120
Bravo
AF:
0.0768
Asia WGS
AF:
0.0360
AC:
123
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
3.1
DANN
Benign
0.71
PhyloP100
-0.71
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17882023; hg19: chr16-31103336; API